AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Rectal Carcinoma

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer๏ผˆSPARKLE๏ผ‰ NCT06767007Phase 21 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Stereotactic Body Radiation Therapy (SBRT), PD1, Chemotherapy Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ New Haven Pfizer ยท Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site๐Ÿ“ Bern University of Bern Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer NCT06307548Phase 1, Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Aminolevulinic Acid, Biospecimen Collection, Computed Tomography, Fluorescence-Guided Surgery, Magnetic Resonance Imagiโ€ฆ Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery NCT03051464Phase 2, Phase 34 sites๐Ÿ“ Dallas๐Ÿ“ Montreal๐Ÿ“ Montreal Sir Mortimer B. Davis - Jewish General Hospital ยท Tests: Complete responders and Non-complete responders, Chemoradiation + EBRT Boost, Chemoradiation + HDRBT Boost A Prospective, Single-Arm Clinical Study of a Dietary Supplement for the Prevention of Acute Radiation-Induced Rectal Injury During Neoadjuvant Chemoradiotherapy for Rectal Cancer NCT07802002NA1 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Tributyrin Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery NCT04103372NA23 sites๐Ÿ“ Reading๐Ÿ“ Amersham๐Ÿ“ London Imperial College London ยท Tests: MRI scan, Radiologist training Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC NCT07448077Phase 21 site๐Ÿ“ Shijiazhuang Hebei Medical University Fourth Hospital ยท Tests: Experimental: short-course radiotherapy and immunotherapy, Chemoradiotherapy CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma NCT05752136Phase 31 site๐Ÿ“ Hangzhou Sir Run Run Shaw Hospital ยท Tests: Envafolimab TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites๐Ÿ“ London๐Ÿ“ Manchester๐Ÿ“ Southampton Cancer Research UK ยท Tests: TT-702, Anti-PD-1 and PD-L1 agent KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Darlifarnib, Cabozantinib, Adagrasib A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Grand Rapids๐Ÿ“ Long Island City Pfizer ยท Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer NCT06530303Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine, Interleukin-2, Pembrolizumab An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response NCT04796818NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Diffusion Weighted Imaging AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Atlanta Amgen ยท Tests: AMG 410, Pembrolizumab, Panitumumab Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer NCT07458529Phase 21 site๐Ÿ“ Beijing Seventh Medical Center of PLA General Hospital ยท Tests: CRT+PD-1 inhibitor+Probio-M9, CRT+PD-1 inhibitor+placebo ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer NCT06589388n/a1 site๐Ÿ“ Ho Chi Minh City Gene Solutions Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy NCT05965531Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Trifluridine/Tipiracil, intensity-modulated radiotherapy Colorectal Cancer Screnning Colonoscopy Under Hypnosis NCT05051046NA1 site๐Ÿ“ Angers University Hospital, Tours ยท Tests: Colonoscopy under hypnosis Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site๐Ÿ“ London Royal Marsden NHS Foundation Trust ยท Tests: Marsden360 ctDNA test and GTAB review Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165n/a1 site๐Ÿ“ Xi'an Xijing Hospital 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors NCT07300150Phase 19 sites๐Ÿ“ Boston๐Ÿ“ San Antonio๐Ÿ“ San Antonio PAQ Therapeutics, Inc. ยท Tests: PT0511, Cetuximab Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT) NCT07026422Phase 21 site๐Ÿ“ Jinan Shandong Cancer Hospital and Institute ยท Tests: Total neoadjuvant therapy integrating iparomlimab/tuvonralimab with chemoradiotherapy Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial NCT06563388Phase 31 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Stereotactic Ablative Radiotherapy, Best Practice Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer NCT05950503n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Hepatic MRI Immunotherapy in Patients With Early dMMR Rectal Cancer NCT05732389Phase 25 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus๐Ÿ“ Copenhagen Odense University Hospital ยท Tests: Nivolumab, Ipilimumab Watch and Wait as Treatment for Patients With Rectal Cancer NCT03125343NA2 sites๐Ÿ“ Gothenburg๐Ÿ“ Stockholm Sahlgrenska University Hospital ยท Tests: endoscopy, Surgery, MRI
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy